Addressing cardiovascular risk after adverse pregnancy outcomes: a health equity-focused qualitative review

Victoria Hodges, Caroline Mitchell, Carolyn Chew-Graham

  • 1Keele University, Keele, UK.

Insights

Women experiencing adverse pregnancy outcomes (APOs) face higher cardiovascular disease (CVD) risks. Postnatal lifestyle interventions are desired, but barriers like inadequate postpartum care and self-prioritization guilt hinder progress, especially for high-risk groups.

Area of Science:

  • Obstetrics and Gynecology
  • Public Health
  • Cardiology

Background:

  • Adverse pregnancy outcomes (APOs), including hypertensive disorders of pregnancy (HDP), preterm labor, and fetal growth restriction, significantly increase long-term cardiovascular disease (CVD) risk.
  • This elevated risk disproportionately affects women from ethnic minorities and socio-economically deprived backgrounds.
  • Women with a history of APOs have a doubled risk of CVD, with pre-eclampsia linked to premature mortality from CVD.

Purpose of the Study:

  • To review women's perspectives on postnatal lifestyle interventions aimed at mitigating long-term CVD risk.
  • Focus on identifying the needs and preferences of highest-risk groups, including ethnic minorities and socio-economically deprived women.

Main Methods:

  • Qualitative systematic review and thematic synthesis.
  • Analysis of qualitative components from research papers reporting on women's views regarding CVD risk management after APOs.
  • Protocol registered on PROSPERO (CRD420250654735).

Main Results:

  • Pregnancy can motivate lifestyle changes, but significant barriers exist, including insufficient physical/psychological recovery and guilt over self-care.
  • Women reported feeling abandoned post-partum, contrasting the intensive monitoring during pregnancy with inadequate postnatal care.
  • A strong desire for structured, formal postnatal follow-up was identified, particularly among high-risk groups who are less likely to seek care independently.

Conclusions:

  • Postnatal care for women with APOs is inadequate, leading to unmet needs for lifestyle interventions.
  • Structured follow-up and community-based support are crucial for addressing long-term CVD risk in these women.
  • Future research and interventions should prioritize co-design with community groups to improve engagement and outcomes.
Abstract

Related Concept Videos

Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...